Microbiome
Modifying the Gut Microbiome to Improve CAR-T, HSCT, and Other Therapeutic Responses
Stacy Burns-Guydish, Ph.D.
List Labs
PAO-10-23-CL-07-33Nov 01, 2023
Cell Therapy
Engineering Immune Cells to Realize the Promise of Cancer Cell Therapies
Beau Webber, Ph.D.
Luminary Therapeutics
PAO-08-23-CL-04Sep 05, 2023
T Cell Expansion Platform
Terumo Blood and Cell Technologies Presents First Quantum® Flex Data for Multiple Size Bioreactors Showing Rapid T Cell Expansion to Numbers Equivalent of a Therapeutic Dose
Terumo Blood and Cell Technologies
PR-M02-23-03Feb 23, 2023
CAR-T
Enabling Greater Patient Access to CAR-T Cell Therapies with Off-the-Shelf Delivery Solutions
Ryan Larson, Ph.D.
PAO-12-022-CL-04Jan 03, 2023
CAR-T and iPSC Platform Technologies
Umoja Biopharma Presents New Preclinical Data on its Integrated In Vivo CAR-T and Engineered iPSC Platform Technologies at the SITC 37th Annual Meeting
Umoja Biopharma
PR-M11-22-06Nov 11, 2022
CRISPR Research Innovation
A Cellular Engineering Breakthrough: High-Yield CRISPR Without Viral Vectors
Gladstone Institutes
PR-M08-22-05Aug 25, 2022
Cell Therapy
Targeting Cancers by Leveraging the Biology of Gamma Delta T Cells
Bryan Kobel
TC Biopharm
PAO-07-022-CL-03Aug 09, 2022
Column: Clinical Trials
CAR-T Study Shines New Spotlight on Clinical Trials Representation
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-022--NI-06Jul 02, 2022
Cell Therapy
Taking Adoptive Cell Therapies to the Next Level
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-022--NI-04Jun 24, 2022
Phase I Trial
Anixa Biosciences Announces the Initiation of its Ovarian Cancer CAR-T Phase I Trial at Moffitt Cancer Center
Anixa Biosciences
PR-M03-22-17Mar 30, 2022
Immunotherapy Research
Genetically Engineered Dual Receptor T-cells: Double Trouble for Cancer Cells
Juntendo University
PR-M01-22-23Jan 31, 2022
Cell and Gene Therapy
A Novel Approach to Drive Disruptive Innovation in Cell and Gene Therapy
Mike Nicholson, Ph.D.
Inceptor Bio
PAO-10-21-CL-14Oct 22, 2021
Cell and Gene Therapy
Expanding a Comprehensive Platform to Support the Future of Cell and Gene Therapies
David Y. H. Chang, Ph.D.
WuXi Advanced Therapies
PAO-05-21-CL-05May 27, 2021
Cell and Gene Therapy
CAR-T Cell and Gene Therapy Market: Challenges and Opportunities
Jason Rahal
Nice Insight
PA1009Apr 21, 2021
Cell Therapy
Economically Viable, Same-Day Autologous Cell Therapies
Gregory Frost, Ph.D.; Sid Kerkar, M.D.
EXUMA Biotechnology
PAO-01-21-CL-06Feb 04, 2021
The Future of Healthcare
How Does Inceptor Bio Envision the Future of the Pharma/Biopharma Industry?
Inceptor Bio
PAP-Q4-20-RT2-002Dec 09, 2020
In Conversation
Novel Off-The-Shelf Targeted Cell Therapies
Gary Lord; Dago Caceres; David Alvaro, Ph.D.; Sonny Hsiao, Ph.D.
Dow Chemicals
PAP-Q2-20-CL-021Jul 01, 2020
CAR-T Cell Therapy
WuXi Advanced Therapies Launches New Closed Process CAR-T Cell Therapy Platform
WuXi Advanced Therapies
PR-M05-20-NI-025May 18, 2020
CAR-T
Leveraging Natural Killer Cells as CAR-T Therapies
Filippo Petti
Celyad
PAP-Q4-19-CL-013Dec 06, 2019
CAR-T Immunotherapy
Cabaletta Bio Announces Presentation of Preclinical Data Showing Specific CAAR T Activity against Anti-MuSK Expressing B Cells
Cabaletta Bio
PR-M10-19-NI-024Oct 15, 2019